post-transcriptional regulation of gene expression following toxic injury

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:6 publications

Grant number: MC_PC_24008

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2024.0
    2027.0
  • Known Financial Commitments (USD)

    $3,274,986.6
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    . Anne Willis
  • Research Location

    United Kingdom
  • Lead Research Institution

    UNIVERSITY OF CAMBRIDGE
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

DNA is the 'code of life' storing all the instructions a cell needs, however the information contained in DNA needs to be translated to produce functional proteins. To achieve this an intermediate message, called messenger RNA (mRNA), is generated from the DNA, which is then "read" by large, complex machines called ribosomes, that act as translators travelling along the mRNA reading the instructions of how to build specific proteins. Following exposure to both environmental and therapeutic compounds mRNA can be damaged, and this can result in the misreading of the mRNA by ribosomes or the ribosomes stalling on the mRNA and colliding. Such ribosome collisions are "sensed" by the cell and this activates a number of different cell stress pathway but in particular the ribosome stress response. The aim of this project is to understand more precisely how the ribosome stress response is triggered. This work is important to human health since certain advanced therapeutics contain mRNA, for example the COVID-19 mRNA vaccines. Knowledge from this work will help us to understand how modified mRNAs in vaccines affect such cellular processes, and so can inform the safe design of these new therapeutics.

Publicationslinked via Europe PMC

Last Updated:15 hours ago

View all publications at Europe PMC

Let's (P-s)talk about specialized ribosomes.

Eukaryotic initiation factor 4B is a multi-functional RNA binding protein that regulates histone mRNAs.

Interrogation of RNA-protein interaction dynamics in bacterial growth.

HSP70 binds to specific non-coding RNA and regulates human RNA polymerase III.

N<sup>1</sup>-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting.

System-wide analysis of RNA and protein subcellular localization dynamics.